Nanomedicines for the treatment of infectious diseases: Formulation, delivery and commercialization aspects. Dube A. A Dube, B Semete-Makokotlela… - Green Synthesis in …, 2021 - taylorfrancis.com GSID: j40KDdS5q9MJ
Comparative studies of the seven human coronavirus envelope proteins using topology prediction and molecular modelling to understand their pathogenicity. Schoeman D, Cloete R, Fielding BC. D Schoeman, R Cloete, BC Fielding - bioRxiv, 2021 - biorxiv.org GSID: rHLS3mtldKwJ
A Perspective on Nanotechnology and COVID-19 Vaccine Research and Production in South Africa. Dube A, Egieyeh S, Balogun M. A Dube, S Egieyeh, M Balogun - Viruses, 2021 - mdpi.com GSID: G80xVqEjOEoJ
A perspective on nanotechnology and covid-19 vaccine research and production in south africa. Egieyeh S, Dube A. S Egieyeh, A Dube - 2021 - repository.uwc.ac.za GSID: Y2xsukEJdAgJ
Strategies for Implementation Research to Investigate the Negative Pharmacokinetic Interaction Between Efavirenz and Dolutegravir. [No authors listed] GD Morse - Clinical Infectious Diseases, 2021 - academic.oup.com GSID: C6H_xSoZ4R8J
